745 filings
8-K
BPMC
Blueprint Medicines Corp
25 May 23
Entry into a Material Definitive Agreement
4:32pm
8-K
BPMC
Blueprint Medicines Corp
22 May 23
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
4:53pm
10-Q
2023 Q1
BPMC
Blueprint Medicines Corp
Quarterly report
4 May 23
4:23pm
8-K
BPMC
Blueprint Medicines Corp
4 May 23
Blueprint Medicines Reports First Quarter 2023 Results
7:18am
ARS
2022 FY
BPMC
Blueprint Medicines Corp
28 Apr 23
Annual report to shareholders
5:47pm
DEFA14A
BPMC
Blueprint Medicines Corp
28 Apr 23
Additional proxy soliciting materials
5:30pm
DEF 14A
BPMC
Blueprint Medicines Corp
Definitive proxy
28 Apr 23
5:30pm
8-K
BPMC
Blueprint Medicines Corp
28 Mar 23
Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222
5:04pm
4
Christopher K. Murray
8 Mar 23
Blueprint Medicines / Christopher K. Murray ownership change
9:38pm
4
Christina Rossi
8 Mar 23
Blueprint Medicines / Christina Rossi ownership change
9:36pm
4
Fouad Namouni
8 Mar 23
Blueprint Medicines / Fouad Namouni ownership change
9:34pm
4
L. Becker Hewes
8 Mar 23
Blueprint Medicines / L. Becker Hewes ownership change
9:33pm
4
Philina Lee
8 Mar 23
Blueprint Medicines / Philina Lee ownership change
9:32pm
4
Debra Durso-Bumpus
8 Mar 23
Blueprint Medicines / Debra Durso-Bumpus ownership change
9:31pm
4
Percy H. Carter
8 Mar 23
Blueprint Medicines / Percy H. Carter ownership change
9:29pm
4
Jeffrey W. Albers
8 Mar 23
Blueprint Medicines / Jeffrey W. Albers ownership change
9:28pm
4
Tracey L McCain
8 Mar 23
Blueprint Medicines / Tracey L McCain ownership change
9:27pm
4
Michael Landsittel
8 Mar 23
Blueprint Medicines / Michael Landsittel ownership change
9:26pm
4
Ariel Hurley
8 Mar 23
Blueprint Medicines / Ariel Hurley ownership change
9:25pm
4
Kate Haviland
8 Mar 23
Blueprint Medicines / Kate Haviland ownership change
9:24pm